Q3 2022 Holdings
Filed 2022-11-14 | 64 holdings | $21.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.3M | 100,000 | 48.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.1M | 65,000 | 14.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.3M | 154,087 | 10.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.2M | 80,000 | 10.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.1M | 136,434 | 10.0% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $981.0K | 883,654 | 4.6% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $89.3K | 250,000 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $17.8K | 326,668 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $16.0K | 813,998 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $12.9K | 190,000 | 0.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $11.5K | 70,000 | 0.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $11.4K | 300,000 | 0.1% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $11.1K | $11,000,000 | 0.1% |
| Sanofi(SNY)Put | SPONSORED ADR | 80105N105 | $9.5K | 250,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $9.2K | 675,753 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $9.1K | 130,000 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $8.7K | 120,000 | 0.0% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $8.5K | $10,000,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $8.2K | 150,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $6.5K | 100,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $5.9K | 170,000 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $5.8K | 746,576 | 0.0% |
| Astrazeneca PLC(AZN)Put | SPONSORED ADR | 046353108 | $5.5K | 100,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $5.0K | 473,597 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $5.0K | 175,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL)Put | COM | 558868105 | $4.9K | 75,000 | 0.0% |
| Penumbra Inc(PEN)Call | COM | 70975L107 | $4.7K | 25,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.5K | 1,290,511 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $4.5K | $7,500,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $4.4K | $10,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.3K | 267,794 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $4.1K | 146,491 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.9K | 210,138 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.7K | 170,000 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.6K | 400,043 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADR | 925050106 | $3.6K | 350,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $3.5K | 352,500 | 0.0% |
| GSK PLC(GSK)Put | SPONSORED ADR | 37733W204 | $3.2K | 110,000 | 0.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $2.2K | 75,000 | 0.0% |
| Lantheus Hldgs Inc(LNTH)Put | COM | 516544103 | $2.1K | 30,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $2.1K | 1,492,771 | 0.0% |
| Invesco Currencyshares Euro(FXE)Put | EURO SHS | 46138K103 | $1.8K | 20,000 | 0.0% |
| Verona Pharma PLC(VRNA)Put | SPONSORED ADR | 925050106 | $1.7K | 165,100 | 0.0% |
| Geron Corp(GERN)Put | COM | 374163103 | $1.5K | 650,000 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $1.5K | 25,000 | 0.0% |
| Geron Corp(GERN)Call | COM | 374163103 | $1.5K | 626,000 | 0.0% |
| Precigen Inc | NOTE 3.500% 7/0 | 46122TAA0 | $1.5K | $1,500,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.4K | 96,318 | 0.0% |
| Milestone Pharmaceuticals in(MIST)Call | COM | 59935V107 | $1.3K | 137,200 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $1.1K | 550,000 | 0.0% |